PDB Short entry for 3S41 HEADER TRANSFERASE 18-MAY-11 3S41 TITLE GLUCOKINASE IN COMPLEX WITH ACTIVATOR AND GLUCOSE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUCOKINASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: SEQUENCE DATABASE RESIDUES 12-465; COMPND 5 SYNONYM: HEXOKINASE TYPE IV, HK IV, HEXOKINASE-4, HK4, HEXOKINASE-D; COMPND 6 EC: 2.7.1.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: GCK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28B KEYWDS DIABETES MELLITUS, DISEASE MUTATION, GLYCOLYSIS, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.LIU REVDAT 3 13-SEP-23 3S41 1 HETSYN REVDAT 2 29-JUL-20 3S41 1 COMPND REMARK SEQADV HETNAM REVDAT 2 2 1 LINK SITE REVDAT 1 14-SEP-11 3S41 0 JRNL AUTH J.A.PFEFFERKORN,A.GUZMAN-PEREZ,P.J.OATES,J.LITCHFIELD, JRNL AUTH 2 G.ASPNES,A.BASAK,J.BENBOW,M.A.BERLINER,J.BIAN,C.CHOI, JRNL AUTH 3 K.FREEMAN-COOK,J.W.CORBETT,M.DIDIUK,J.R.DUNETZ,K.J.FILIPSKI, JRNL AUTH 4 W.M.HUNGERFORD,C.S.JONES,K.KARKI,A.LING,J.-C.LI,L.PATEL, JRNL AUTH 5 C.PERREAULT,H.RISLEY,J.SAENZ,W.SONG,M.TU,R.AIELLO, JRNL AUTH 6 K.ATKINSON,N.BARUCCI,D.BEEBE,P.BOURASSA,F.BOURBOUNAIS, JRNL AUTH 7 A.M.BRODEUR,R.BURBEY,J.CHEN,T.D'AQUILA,D.R.DERKSEN, JRNL AUTH 8 N.HADDISH-BERHANE,C.HUANG,J.LANDRO,A.L.LAPWORTH, JRNL AUTH 9 M.MACDOUGALL,D.PERREGAUX,J.PETTERSEN,A.ROBERTSON,B.TAN, JRNL AUTH10 J.L.TREADWAY,S.LIU,X.QIU,J.KNAFELS,M.AMMIRATI,X.SONG, JRNL AUTH11 P.DASILVA-JARDINE,S.LIRAS,L.SWEET,T.P.ROLPH JRNL TITL DESIGNING GLUCOKINASE ACTIVATORS WITH REDUCED HYPOGLYCEMIA JRNL TITL 2 RISK: DISCOVERY OF JRNL TITL 3 N,N-DIMETHYL-5-(2-METHYL-6-((5-METHYLPYRAZIN-2-YL) JRNL TITL 4 -CARBAMOYL)BENZOFURAN-4-YLOXY)PYRIMIDINE-2-CARBOXAMIDE AS A JRNL TITL 5 CLINICAL CANDIDATE FOR THE TREATMENT OF TYPE 2 DIABETES JRNL TITL 6 MELLITUS JRNL REF MEDCHEMCOMM V. 2 828 2011 JRNL REFN ISSN 2040-2503 JRNL DOI 10.1039/C1MD00116G REMARK 2 REMARK 2 RESOLUTION. 2.18 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.9.3 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.18 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 52.90 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 86.9 REMARK 3 NUMBER OF REFLECTIONS : 22127 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.246 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.990 REMARK 3 FREE R VALUE TEST SET COUNT : 1105 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.18 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.29 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 86.85 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1239 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2015 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1173 REMARK 3 BIN R VALUE (WORKING SET) : 0.1992 REMARK 3 BIN FREE R VALUE : 0.2414 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.33 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 66 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3506 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 181 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.91 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.23570 REMARK 3 B22 (A**2) : -4.54480 REMARK 3 B33 (A**2) : 1.30910 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.266 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.342 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.234 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.316 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.231 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.927 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.878 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 3651 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 4918 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1361 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 102 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 539 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 3651 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 460 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4397 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.17 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.04 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.26 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3S41 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-MAY-11. REMARK 100 THE DEPOSITION ID IS D_1000065733. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22198 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.180 REMARK 200 RESOLUTION RANGE LOW (A) : 82.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 87.1 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.11500 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 3FGU REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.12 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.24 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, PH 7.5, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 33.50500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.08000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.10000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 43.08000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 33.50500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.10000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 HIS A 1 REMARK 465 HIS A 2 REMARK 465 HIS A 3 REMARK 465 GLU A 93 REMARK 465 GLY A 94 REMARK 465 GLU A 95 REMARK 465 GLU A 96 REMARK 465 GLY A 97 REMARK 465 GLN A 98 REMARK 465 TRP A 99 REMARK 465 LYS A 459 REMARK 465 ALA A 460 REMARK 465 CYS A 461 REMARK 465 MET A 462 REMARK 465 LEU A 463 REMARK 465 GLY A 464 REMARK 465 GLN A 465 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 67 CB CG CD OE1 OE2 REMARK 470 LYS A 140 CD CE NZ REMARK 470 LYS A 142 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 5 107.63 65.42 REMARK 500 GLU A 67 -151.58 140.61 REMARK 500 ASN A 83 -174.02 78.41 REMARK 500 GLN A 138 73.73 46.11 REMARK 500 MET A 139 22.62 -159.12 REMARK 500 LYS A 140 4.04 -69.18 REMARK 500 LYS A 172 16.59 -141.27 REMARK 500 ARG A 345 3.20 83.14 REMARK 500 ARG A 358 73.72 -115.04 REMARK 500 THR A 431 60.08 -118.19 REMARK 500 CYS A 457 25.36 -65.43 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 600 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 MET A 238 O REMARK 620 2 VAL A 241 O 89.8 REMARK 620 3 VAL A 244 O 146.9 81.1 REMARK 620 4 GLY A 246 O 80.7 166.6 101.8 REMARK 620 N 1 2 3 DBREF 3S41 A 12 465 UNP P35557 HXK4_HUMAN 12 465 SEQADV 3S41 MET A -3 UNP P35557 EXPRESSION TAG SEQADV 3S41 HIS A -2 UNP P35557 EXPRESSION TAG SEQADV 3S41 HIS A -1 UNP P35557 EXPRESSION TAG SEQADV 3S41 HIS A 0 UNP P35557 EXPRESSION TAG SEQADV 3S41 HIS A 1 UNP P35557 EXPRESSION TAG SEQADV 3S41 HIS A 2 UNP P35557 EXPRESSION TAG SEQADV 3S41 HIS A 3 UNP P35557 EXPRESSION TAG SEQADV 3S41 GLU A 4 UNP P35557 EXPRESSION TAG SEQADV 3S41 ASN A 5 UNP P35557 EXPRESSION TAG SEQADV 3S41 LEU A 6 UNP P35557 EXPRESSION TAG SEQADV 3S41 TYR A 7 UNP P35557 EXPRESSION TAG SEQADV 3S41 PHE A 8 UNP P35557 EXPRESSION TAG SEQADV 3S41 GLN A 9 UNP P35557 EXPRESSION TAG SEQADV 3S41 GLY A 10 UNP P35557 EXPRESSION TAG SEQADV 3S41 MET A 11 UNP P35557 EXPRESSION TAG SEQRES 1 A 469 MET HIS HIS HIS HIS HIS HIS GLU ASN LEU TYR PHE GLN SEQRES 2 A 469 GLY MET LYS LYS GLU LYS VAL GLU GLN ILE LEU ALA GLU SEQRES 3 A 469 PHE GLN LEU GLN GLU GLU ASP LEU LYS LYS VAL MET ARG SEQRES 4 A 469 ARG MET GLN LYS GLU MET ASP ARG GLY LEU ARG LEU GLU SEQRES 5 A 469 THR HIS GLU GLU ALA SER VAL LYS MET LEU PRO THR TYR SEQRES 6 A 469 VAL ARG SER THR PRO GLU GLY SER GLU VAL GLY ASP PHE SEQRES 7 A 469 LEU SER LEU ASP LEU GLY GLY THR ASN PHE ARG VAL MET SEQRES 8 A 469 LEU VAL LYS VAL GLY GLU GLY GLU GLU GLY GLN TRP SER SEQRES 9 A 469 VAL LYS THR LYS HIS GLN MET TYR SER ILE PRO GLU ASP SEQRES 10 A 469 ALA MET THR GLY THR ALA GLU MET LEU PHE ASP TYR ILE SEQRES 11 A 469 SER GLU CYS ILE SER ASP PHE LEU ASP LYS HIS GLN MET SEQRES 12 A 469 LYS HIS LYS LYS LEU PRO LEU GLY PHE THR PHE SER PHE SEQRES 13 A 469 PRO VAL ARG HIS GLU ASP ILE ASP LYS GLY ILE LEU LEU SEQRES 14 A 469 ASN TRP THR LYS GLY PHE LYS ALA SER GLY ALA GLU GLY SEQRES 15 A 469 ASN ASN VAL VAL GLY LEU LEU ARG ASP ALA ILE LYS ARG SEQRES 16 A 469 ARG GLY ASP PHE GLU MET ASP VAL VAL ALA MET VAL ASN SEQRES 17 A 469 ASP THR VAL ALA THR MET ILE SER CYS TYR TYR GLU ASP SEQRES 18 A 469 HIS GLN CYS GLU VAL GLY MET ILE VAL GLY THR GLY CYS SEQRES 19 A 469 ASN ALA CYS TYR MET GLU GLU MET GLN ASN VAL GLU LEU SEQRES 20 A 469 VAL GLU GLY ASP GLU GLY ARG MET CYS VAL ASN THR GLU SEQRES 21 A 469 TRP GLY ALA PHE GLY ASP SER GLY GLU LEU ASP GLU PHE SEQRES 22 A 469 LEU LEU GLU TYR ASP ARG LEU VAL ASP GLU SER SER ALA SEQRES 23 A 469 ASN PRO GLY GLN GLN LEU TYR GLU LYS LEU ILE GLY GLY SEQRES 24 A 469 LYS TYR MET GLY GLU LEU VAL ARG LEU VAL LEU LEU ARG SEQRES 25 A 469 LEU VAL ASP GLU ASN LEU LEU PHE HIS GLY GLU ALA SER SEQRES 26 A 469 GLU GLN LEU ARG THR ARG GLY ALA PHE GLU THR ARG PHE SEQRES 27 A 469 VAL SER GLN VAL GLU SER ASP THR GLY ASP ARG LYS GLN SEQRES 28 A 469 ILE TYR ASN ILE LEU SER THR LEU GLY LEU ARG PRO SER SEQRES 29 A 469 THR THR ASP CYS ASP ILE VAL ARG ARG ALA CYS GLU SER SEQRES 30 A 469 VAL SER THR ARG ALA ALA HIS MET CYS SER ALA GLY LEU SEQRES 31 A 469 ALA GLY VAL ILE ASN ARG MET ARG GLU SER ARG SER GLU SEQRES 32 A 469 ASP VAL MET ARG ILE THR VAL GLY VAL ASP GLY SER VAL SEQRES 33 A 469 TYR LYS LEU HIS PRO SER PHE LYS GLU ARG PHE HIS ALA SEQRES 34 A 469 SER VAL ARG ARG LEU THR PRO SER CYS GLU ILE THR PHE SEQRES 35 A 469 ILE GLU SER GLU GLU GLY SER GLY ARG GLY ALA ALA LEU SEQRES 36 A 469 VAL SER ALA VAL ALA CYS LYS LYS ALA CYS MET LEU GLY SEQRES 37 A 469 GLN HET GLC A 500 12 HET NA A 600 1 HET S41 A4000 32 HETNAM GLC ALPHA-D-GLUCOPYRANOSE HETNAM NA SODIUM ION HETNAM S41 N,N-DIMETHYL-5-({2-METHYL-6-[(5-METHYLPYRAZIN-2-YL) HETNAM 2 S41 CARBAMOYL]-1-BENZOFURAN-4-YL}OXY)PYRIMIDINE-2- HETNAM 3 S41 CARBOXAMIDE HETSYN GLC ALPHA-D-GLUCOSE; D-GLUCOSE; GLUCOSE FORMUL 2 GLC C6 H12 O6 FORMUL 3 NA NA 1+ FORMUL 4 S41 C22 H20 N6 O4 FORMUL 5 HOH *181(H2 O) HELIX 1 1 ASN A 5 ALA A 21 1 17 HELIX 2 2 GLU A 22 GLN A 24 5 3 HELIX 3 3 GLN A 26 ARG A 46 1 21 HELIX 4 4 PRO A 111 THR A 116 1 6 HELIX 5 5 THR A 118 HIS A 137 1 20 HELIX 6 6 ASN A 180 GLY A 193 1 14 HELIX 7 7 ASN A 204 ASP A 217 1 14 HELIX 8 8 GLN A 239 VAL A 241 5 3 HELIX 9 9 GLU A 256 PHE A 260 5 5 HELIX 10 10 LEU A 266 LEU A 270 5 5 HELIX 11 11 LEU A 271 SER A 280 1 10 HELIX 12 12 TYR A 289 ILE A 293 5 5 HELIX 13 13 GLY A 294 GLU A 312 1 19 HELIX 14 14 LEU A 315 GLU A 319 5 5 HELIX 15 15 GLU A 331 ASP A 341 1 11 HELIX 16 16 ARG A 345 LEU A 355 1 11 HELIX 17 17 SER A 360 ARG A 397 1 38 HELIX 18 18 GLY A 410 HIS A 416 1 7 HELIX 19 19 SER A 418 THR A 431 1 14 HELIX 20 20 GLU A 443 CYS A 457 1 15 SHEET 1 A 6 LEU A 58 ARG A 63 0 SHEET 2 A 6 ARG A 250 ASN A 254 -1 O ASN A 254 N LEU A 58 SHEET 3 A 6 CYS A 230 GLU A 237 -1 N TYR A 234 O VAL A 253 SHEET 4 A 6 CYS A 220 VAL A 226 -1 N ILE A 225 O ASN A 231 SHEET 5 A 6 MET A 402 ASP A 409 1 O GLY A 407 N VAL A 222 SHEET 6 A 6 CYS A 434 GLU A 440 1 O GLU A 435 N MET A 402 SHEET 1 B 5 LYS A 102 TYR A 108 0 SHEET 2 B 5 PHE A 84 VAL A 91 -1 N PHE A 84 O TYR A 108 SHEET 3 B 5 GLY A 72 LEU A 79 -1 N GLY A 72 O VAL A 91 SHEET 4 B 5 LEU A 144 PHE A 150 1 O THR A 149 N LEU A 77 SHEET 5 B 5 MET A 197 VAL A 203 1 O ALA A 201 N PHE A 148 SHEET 1 C 2 VAL A 154 ASP A 158 0 SHEET 2 C 2 LYS A 161 LEU A 164 -1 O LYS A 161 N GLU A 157 LINK O MET A 238 NA NA A 600 1555 1555 2.35 LINK O VAL A 241 NA NA A 600 1555 1555 2.26 LINK O VAL A 244 NA NA A 600 1555 1555 2.27 LINK O GLY A 246 NA NA A 600 1555 1555 2.30 CRYST1 67.010 82.200 86.160 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014923 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012165 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011606 0.00000